27 Article(s)Download |
PMID | Title | Pub. Year | #Total Relationships |
1 | 30944635 | 5-Fluorouracil-based adjuvant chemotherapy improves the clinical outcomes of patients with lymphovascular invasion of upper urinary tract cancer and low expression of dihydropyrimidine dehydrogenase. | 2019 May | 2 |
2 | 28835573 | Higher Tissue Levels of Thymidylate Synthase Determined by ELISA Are Associated with Poor Prognosis of Patients with Lung Cancer. | 2017 Aug | 1 |
3 | 26651493 | Uncommon dihydropyrimidine dehydrogenase mutations and toxicity by fluoropyrimidines: a lethal case with a new variant. | 2016 | 1 |
4 | 23585145 | Fluoropyrimidine toxicity in patients with dihydropyrimidine dehydrogenase splice site variant: the need for further revision of dose and schedule. | 2013 Aug | 2 |
5 | 28520376 | Fluorouracil Therapy and DPYD Genotype | 2012 | 1 |
6 | 21378348 | A phase I study evaluating the effect of CDHP as a component of S-1 on the pharmacokinetics of 5-fluorouracil. | 2011 Feb | 1 |
7 | 20146975 | [Dihydropyrimidine dehydrogenase deficiency and toxicity to fluoropyrimidine]. | 2010 Jan-Feb | 4 |
8 | 19015148 | Comparison of 5-fluorouracil-related gene expression levels between adenocarcinomas and squamous cell carcinomas of the lung. | 2009 Jan | 2 |
9 | 17143493 | Cyclophosphamide augments the anti-tumor efficacy of uracil and tegafur by inhibiting dihydropyrimidine dehydrogenase. | 2007 Jan | 2 |
10 | 17603216 | Development of a pharmacokinetic model to optimize the dosage regimen of TS-1, a combination preparation of tegafur, gimeracil and oteracil potassium. | 2007 Jun | 4 |
11 | 17695427 | Predictive value of thymidylate synthase and dihydropyrimidine dehydrogenase expression in tumor tissue, regarding the efficacy of postoperatively administered UFT (tegafur+uracil) in patients with non-small cell lung cancer. | 2007 Jul-Aug | 1 |
12 | 17952005 | Dihydropyrimidine dehydrogenase activity during long-term adjuvant treatment with oral uracil and tegafur for colorectal cancer. | 2007 | 1 |
13 | 16897969 | [Pharmacokinetics of S-1]. | 2006 Jun | 4 |
14 | 16897985 | Rapid development of S-1 in the west for therapy of advanced gastric carcinoma. | 2006 Jun | 2 |
15 | 15598584 | Dihydropyrimidine dehydrogenase expression predicts survival outcome and chemosensitivity to 5-fluorouracil in patients with oral squamous cell carcinoma. | 2005 Jan | 2 |
16 | 15363468 | The role of uracil-tegafur (UFT) in elderly patients with colorectal cancer. | 2004 Oct | 2 |
17 | 12775012 | S-1 in gastric cancer: a comprehensive review. | 2003 | 1 |
18 | 12851836 | Clinical implications of dihydropyrimidine dehydrogenase (DPD) activity in 5-FU-based chemotherapy: mutations in the DPD gene, and DPD inhibitory fluoropyrimidines. | 2003 Jun | 2 |
19 | 14551502 | Dihydropyrimidine dehydrogenase inhibition as a strategy for the oral administration of 5-fluorouracil: utility in the treatment of advanced colorectal cancer. | 2003 Oct | 1 |
20 | 12111108 | Pharmacokinetic study of S-1, a novel oral fluorouracil antitumor agent in animal model and in patients with impaired renal function. | 2002 Jul | 2 |
21 | 12355409 | Predictive value of dihydropyrimidine dehydrogenase expression in tumor tissue, regarding the efficacy of postoperatively administered UFT (Tegafur + Uracil) in patients with p-stage I nonsmall-cell lung cancer. | 2002 Oct | 2 |
22 | 12464897 | Thymidylate synthase and dihydropyrimidine dehydrogenase expression in oral squamous cell carcinoma: an immunohistochemical and clinicopathologic study. | 2002 Dec | 1 |
23 | 11219978 | UFT in the treatment of colorectal and breast cancer. | 2001 Jan | 2 |
24 | 11679189 | The role of UFT and the combination of UFT/leucovorin in non-small cell lung cancer. | 2001 Nov | 1 |
25 | 11729480 | [Dihydropyrimidine dehydrogenase activity in urothelial cancer--influence of UFT administration on DPD activity]. | 2001 Nov | 1 |
26 | 10473078 | Pharmacokinetic study of S-1, a novel oral fluorouracil antitumor drug. | 1999 Aug | 4 |
27 | 10595802 | Novel oral fluoropyrimidines in the treatment of metastatic colorectal cancer. | 1999 Dec 1 | 2 |